Join SGS at Booth #361 to find out more about our biosafety testing solutions.


May 16, 2022


May 19, 2022


Washington, DC, United States

The American Society of Gene and Cell Therapy’s (ASGCT) Annual Meeting, celebrating its 25th year in 2022, is the premier event for professionals in gene and cell therapy. The four-day meeting is the best place for people in the field to learn from the latest scientific research, stay up to date on new technologies and make career-advancing connections with peers.

Originally designed as a venue for academic researchers to share their work, the Annual Meeting has grown to serve a wide community encompassing clinicians, bio-industry development, regulatory agencies, equipment manufacturers, patient advocates and more.

Our biosafety team has over 25 years experience developing, validating, and running over 300 assays for characterization and biosafety. If you are involved in:

  • Viral vaccines
  • Cell therapies
  • Monoclonal antibodies
  • Recombinant proteins
  • Gene therapies

then you can benefit from working with SGS.

We look forward to meeting you at Booth #361.

For further information, contact:

Josela Renardson
Global Marketing Manager
t: +44 0 121 541 4748